Your browser doesn't support javascript.
loading
Industry corner: perspectives and controversies - The challenges of patient access to new medicines.
Gann, C-N; Morsli, N; Kaiser, R.
Affiliation
  • Gann CN; Boehringer Ingelheim GmbH & Co. KG, Ingelheim, Germany.
  • Morsli N; Boehringer Ingelheim Corporation, Reims, France.
  • Kaiser R; Boehringer Ingelheim Pharmaceuticals GmbH & Co. KG, Biberach, Germany.
Ann Oncol ; 28(3): 658-663, 2017 03 01.
Article in En | MEDLINE | ID: mdl-27831504
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Drug Industry / Health Services Accessibility / Lung Neoplasms Aspects: Determinantes_sociais_saude Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Drug Industry / Health Services Accessibility / Lung Neoplasms Aspects: Determinantes_sociais_saude Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Alemania